semaglutide tirzepatide vs. Tirzepatide: What's the Difference and Which Is Right for You?: Envizion Medical: Wellness Center Semaglutide vs. Tirzepatide for weight

Semaglutide (Wegovy) for the treatment of obesity

Dual receptor agonists can activate both GIP and GLP-1 receptors

GLP-1 receptor agonists, including semaglutide and tirzepatide, were originally developed to treat type 2 diabetes

but my varicose veins have practically disappeared

People treated with a high dose lost an average of 24 percent of their body weight after nearly a year of treatment, a small clinical trial reported this year

Phase 2 clinical trial data published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023) demonstrated substantial weight reduction in participants with obesity